National Pension Service Decreases Holdings in Cencora, Inc. (NYSE:COR)

National Pension Service cut its stake in Cencora, Inc. (NYSE:COR - Free Report) by 1.8% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 302,508 shares of the company's stock after selling 5,411 shares during the quarter. National Pension Service owned about 0.16% of Cencora worth $67,967,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of COR. JFS Wealth Advisors LLC increased its position in Cencora by 63.0% during the fourth quarter. JFS Wealth Advisors LLC now owns 119 shares of the company's stock worth $27,000 after purchasing an additional 46 shares during the last quarter. Householder Group Estate & Retirement Specialist LLC raised its position in shares of Cencora by 85.2% during the 4th quarter. Householder Group Estate & Retirement Specialist LLC now owns 150 shares of the company's stock valued at $33,000 after buying an additional 69 shares during the period. Kentucky Trust Co acquired a new position in Cencora in the fourth quarter valued at approximately $33,000. WASHINGTON TRUST Co grew its position in Cencora by 37.7% in the fourth quarter. WASHINGTON TRUST Co now owns 168 shares of the company's stock worth $38,000 after acquiring an additional 46 shares during the period. Finally, Ashton Thomas Securities LLC purchased a new position in Cencora in the third quarter worth approximately $41,000. Hedge funds and other institutional investors own 97.52% of the company's stock.

Insider Activity at Cencora

In other Cencora news, EVP Silvana Battaglia sold 5,000 shares of Cencora stock in a transaction that occurred on Friday, February 21st. The stock was sold at an average price of $242.24, for a total transaction of $1,211,200.00. Following the transaction, the executive vice president now owns 15,374 shares of the company's stock, valued at $3,724,197.76. The trade was a 24.54 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 10.80% of the company's stock.

Cencora Stock Up 0.7 %

Shares of COR traded up $1.68 during midday trading on Monday, hitting $255.22. The company had a trading volume of 1,367,867 shares, compared to its average volume of 1,500,052. The company's 50-day simple moving average is $241.71 and its 200-day simple moving average is $237.85. The company has a debt-to-equity ratio of 16.40, a quick ratio of 0.54 and a current ratio of 0.92. Cencora, Inc. has a 1 year low of $214.77 and a 1 year high of $262.26. The firm has a market capitalization of $49.49 billion, a P/E ratio of 36.30, a P/E/G ratio of 1.31 and a beta of 0.49.

Cencora (NYSE:COR - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $3.73 EPS for the quarter, topping the consensus estimate of $3.50 by $0.23. Cencora had a net margin of 0.46% and a return on equity of 328.62%. As a group, sell-side analysts expect that Cencora, Inc. will post 15.37 EPS for the current year.

Cencora Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, March 3rd. Stockholders of record on Friday, February 14th will be issued a $0.55 dividend. This represents a $2.20 annualized dividend and a dividend yield of 0.86%. The ex-dividend date is Friday, February 14th. Cencora's payout ratio is 31.29%.

Analysts Set New Price Targets

Several brokerages have recently commented on COR. UBS Group upped their price target on Cencora from $275.00 to $285.00 and gave the company a "buy" rating in a research note on Thursday, November 7th. JPMorgan Chase & Co. upped their target price on shares of Cencora from $289.00 to $301.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Mizuho began coverage on shares of Cencora in a research report on Wednesday, December 4th. They set an "outperform" rating and a $280.00 price target for the company. Evercore ISI upped their price objective on shares of Cencora from $270.00 to $280.00 and gave the stock an "outperform" rating in a report on Thursday, February 6th. Finally, Wells Fargo & Company boosted their price objective on Cencora from $237.00 to $251.00 and gave the company an "equal weight" rating in a report on Wednesday, January 29th. Two analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $277.90.

Cencora Company Profile

Cencora, Inc sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.